Labeler
ViiV Healthcare Company NDC Codes
ViiV Healthcare Company lists 26 finished drug products in the FDA NDC Directory under NDC labeler code 49702.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Cabenuva, Selzentry, Tivicay, Retrovir, Epivir, Apretude, Triumeq PD, Vocabria, Rukobia, Tivicay PD, Dovato, Juluca, Triumeq, Combivir, Ziagen
- Active ingredients
- Dolutegravir sodium, Lamivudine, Zidovudine, Abacavir sulfate, Maraviroc, Cabotegravir sodium, Fostemsavir tromethamine, Rilpivirine hydrochloride
- NDC labeler codes
- 49702
- Strengths
- Dolutegravir sodium 50 mg/1; Lamivudine 300 mg/1; Zidovudine 10 mg/mL; Lamivudine 150 mg/1; Cabotegravir sodium 30 mg/1; Fostemsavir tromethamine 600 mg/1; Dolutegravir sodium 5 mg/1; Rilpivirine hydrochloride 25 mg/1; Dolutegravir sodium 10 mg/1; Dolutegravir sodium 25 mg/1; Abacavir sulfate 600 mg/1; Maraviroc 150 mg/1; Maraviroc 300 mg/1; Zidovudine 100 mg/1; Zidovudine 300 mg/1; Lamivudine 10 mg/mL; Abacavir sulfate 20 mg/mL
- Dosage forms
- Tablet, Film coated, Kit, Solution, Tablet, Film coated, Extended release, Tablet, For suspension, Injection, Solution, Capsule
- Routes
- Oral, Intravenous
- Drug classes (FDA established)
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, CCR5 Co-receptor Antagonist, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 28
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Cabenuvacabotegravir and rilpivirine | — | Kit | 49702-266 | 49702-0266-63 | — |
| Apretudecabotegravir | — | Kit | 49702-280 | 49702-0280-63 | — |
| Triumeq PDabacavir sulfate, dolutegravir sodium, lamivudine | — | Kit | 49702-258 | 49702-0258-37 | — |
| Apretudecabotegravir | — | Kit | 49702-264 | 49702-0264-23 | — |
| Cabenuvacabotegravir and rilpivirine | — | Kit | 49702-240 | 49702-0240-15 | — |
| Vocabriacabotegravir sodium | Cabotegravir sodium 30 mg/1 | Tablet, Film coatedOral | 49702-248 | 49702-0248-13 | — |
| Cabenuvacabotegravir and rilpivirine | — | Kit | 49702-253 | 49702-0253-15 | — |
| Selzentrymaraviroc | — | Kit | 49702-260 | 49702-0260-55 | — |
| Rukobiafostemsavir tromethamine | Fostemsavir tromethamine 600 mg/1 | Tablet, Film coated, Extended releaseOral | 49702-250 | 49702-0250-18 | — |
| Tivicay PDdolutegravir sodium | Dolutegravir sodium 5 mg/1 | Tablet, For suspensionOral | 49702-255 | 49702-0255-37 | — |
| Dovatodolutegravir sodium and lamivudine | Dolutegravir sodium 50 mg/1; Lamivudine 300 mg/1 | Tablet, Film coatedOral | 49702-246 | 49702-0246-1349702-0246-3349702-0246-62 | — |
| Julucadolutegravir sodium and rilpivirine hydrochloride | Dolutegravir sodium 50 mg/1; Rilpivirine hydrochloride 25 mg/1 | Tablet, Film coatedOral | 49702-242 | 49702-0242-13 | — |
| Tivicaydolutegravir sodium | Dolutegravir sodium 10 mg/1 | Tablet, Film coatedOral | 49702-226 | 49702-0226-13 | — |
| Tivicaydolutegravir sodium | Dolutegravir sodium 25 mg/1 | Tablet, Film coatedOral | 49702-227 | 49702-0227-13 | — |
| Triumeqabacavir sulfate, dolutegravir sodium, lamivudine | Abacavir sulfate 600 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 49702-231 | 49702-0231-13 | — |
| Tivicaydolutegravir sodium | Dolutegravir sodium 50 mg/1 | Tablet, Film coatedOral | 49702-228 | 49702-0228-13 | — |
| Selzentrymaraviroc | Maraviroc 150 mg/1 | Tablet, Film coatedOral | 49702-223 | 49702-0223-18 | — |
| Selzentrymaraviroc | Maraviroc 300 mg/1 | Tablet, Film coatedOral | 49702-224 | 49702-0224-18 | — |
| Retrovirzidovudine | Zidovudine 10 mg/mL | Injection, SolutionIntravenous | 49702-213 | 49702-0213-26 | — |
| Retrovirzidovudine | Zidovudine 100 mg/1 | CapsuleOral | 49702-211 | 49702-0211-20 | — |
| Retrovirzidovudine | Zidovudine 10 mg/mL | SolutionOral | 49702-212 | 49702-0212-48 | — |
| Combivirlamivudine and zidovudine | Lamivudine 150 mg/1; Zidovudine 300 mg/1 | Tablet, Film coatedOral | 49702-202 | 49702-0202-18 | — |
| Epivirlamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | 49702-203 | 49702-0203-18 | — |
| Epivirlamivudine | Lamivudine 300 mg/1 | Tablet, Film coatedOral | 49702-204 | 49702-0204-13 | — |
| Epivirlamivudine | Lamivudine 10 mg/mL | SolutionOral | 49702-205 | 49702-0205-48 | — |
| Ziagenabacavir sulfate | Abacavir sulfate 20 mg/mL | SolutionOral | 49702-222 | 49702-0222-48 | — |
ViiV Healthcare Company: common questions
- What is ViiV Healthcare Company's NDC labeler code?
- 49702. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for ViiV Healthcare Company?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.